{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:37:05Z","timestamp":1793702225730,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jacadv.2025.102344","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:15:12Z","timestamp":1763381712000},"page":"102344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-7911","authenticated-orcid":false,"given":"Mari Nordb\u00f8","family":"Gynnild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5962-3341","authenticated-orcid":false,"given":"Victoria","family":"Vinje-Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Holtrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.J.","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Holte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-1613","authenticated-orcid":false,"given":"Siri Lagethon","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-8526","authenticated-orcid":false,"given":"Jannick A.N.","family":"Dorresteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unn Merete","family":"Fagerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-3663","authenticated-orcid":false,"given":"Havard","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-0369","authenticated-orcid":false,"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir","family":"Wethal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.jacadv.2025.102344_bib1","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102344_bib2","first-page":"631","article-title":"Cardiovascular considerations before cancer therapy","volume":"6","author":"Raisi-Estabragh","year":"2024","journal-title":"JACC: CardioOncology"},{"issue":"11","key":"10.1016\/j.jacadv.2025.102344_bib3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102344_bib4","author":"Rossello","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacadv.2025.102344_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: what, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2025.102344_bib6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ejhf.1999","article-title":"Cancer therapy and the heart; the necessity to calibrate risk","volume":"22","author":"Okwuosa","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102344_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041278","article-title":"Heart failure association-international cardio-oncology society risk score validation in HER2-Positive breast cancer","volume":"12","author":"Cronin","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102344_bib8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/jcm11030847","article-title":"Evaluation of risk prediction models to identify cancer therapeutics related cardiac dysfunction in women with HER2+ breast cancer","volume":"11","author":"Suntheralingam","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102344_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/eurheartj\/ehae496","article-title":"Anthracycline-induced cardiovascular toxicity: validation of the heart failure association and international cardio-oncology society risk score","volume":"46","author":"Rivero-Santana","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102344_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-021-06192-w","article-title":"Incidence of cardiotoxicity and validation of the heart failure association-International cardio-oncology society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer","volume":"188","author":"Battisti","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102344_bib11","first-page":"628","article-title":"Cardiotoxicity of BRAF\/MEK inhibitors: a longitudinal study incorporating contemporary definitions and risk scores","volume":"5","author":"Glen","year":"2023","journal-title":"JACC: CardioOncology"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102344_bib12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/ehf2.13897","article-title":"The new HFA\/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity","volume":"9","author":"Di Lisi","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102344_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ije\/dys095","article-title":"Cohort profile: the HUNT study, Norway","volume":"42","author":"Krokstad","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"1-2","key":"10.1016\/j.jacadv.2025.102344_bib15","doi-asserted-by":"crossref","DOI":"10.5324\/nje.v29i1-2.4043","article-title":"INSPIRE: a new opportunity for cancer pharmacoepidemiology research","volume":"29","author":"Enerly","year":"2021","journal-title":"Norsk Epidemiologi"},{"key":"10.1016\/j.jacadv.2025.102344_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/261878","article-title":"Validation of the friedewald formula in patients with metabolic syndrome","volume":"2014","author":"Knopfholz","year":"2014","journal-title":"Cholesterol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102344_bib17","first-page":"67","article-title":"Comparison of heart failure risk assessment tools among cancer survivors","volume":"10","author":"Soh","year":"2024","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jacadv.2025.102344_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2021.11.059","article-title":"Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: the HFA\/ICOS risk tool in real-world practice","volume":"349","author":"Tini","year":"2022","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102344_bib19","first-page":"42","article-title":"Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score","volume":"10","author":"Fernando","year":"2024","journal-title":"Cardiooncology"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102344_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2459\/JCM.0000000000001589","article-title":"The added value of the HFA\/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer","volume":"25","author":"Di Lisi","year":"2024","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"18","key":"10.1016\/j.jacadv.2025.102344_bib21","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/eurjpc\/zwad210","article-title":"Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: kurume-CREO registry insights","volume":"30","author":"Shibata","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacadv.2025.102344_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaccao.2024.05.015","article-title":"Predictive performance of cardiovascular risk scores in cancer survivors from the UK biobank","author":"McCracken","year":"2024","journal-title":"JACC CardioOncology"},{"issue":"7","key":"10.1016\/j.jacadv.2025.102344_bib23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102344_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"19","key":"10.1016\/j.jacadv.2025.102344_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","article-title":"Distribution of estimated 10-Year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacadv.2025.102344_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302181","article-title":"The influence of diagnostic subgroups, patient- and hospital characteristics for the validity of cardiovascular diagnoses\u2013data from a Norwegian hospital trust","volume":"19","author":"Rye","year":"2024","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.jacadv.2025.102344_bib27","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.jacc.2015.04.012","article-title":"Subclinical cardiotoxicity associated with cancer therapy: early detection and future directions","volume":"65","author":"Yeh","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jacadv.2025.102344_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021931","article-title":"Development and validation of a risk score model for predicting the cardiovascular outcomes after breast cancer therapy: the CHEMO-RADIAT score","volume":"10","author":"Kim","year":"2021","journal-title":"J Am Heart Association"},{"issue":"48","key":"10.1016\/j.jacadv.2025.102344_bib29","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehz460","article-title":"Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study","volume":"40","author":"Abdel-Qadir","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102344_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000472","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"3","author":"Ezaz","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2025.102344_bib31","article-title":"ABSDELL model: development and internal validation of a risk prediction model of LVEF decline in breast cancer patients treated with trastuzumab","author":"Liu","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102344_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0569","article-title":"Risk prediction models for cardiotoxicity of chemotherapy among patients with breast cancer: a systematic review","volume":"6","author":"Kabor\u00e9","year":"2023","journal-title":"JAMA Network Open"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25007744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25007744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:07:09Z","timestamp":1771358829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25007744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2772963X25007744"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102344","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102344"}}